The FDA warns about the manufacture medicinal and non-pharmaceutical products on the same equipment
by Giuliana Miglierini A Warning Letter, sent in September 2022 by the US FDA to a German company…
How to approach drug substance supply in new product introduction (NPI) processes
by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
Key issues in technical due diligences
by Giuliana Miglierini Financial due diligence is a central theme when discussing mergers and acquisitions (M&A). Not less…